- Home
- ASRT vs INCR Comparison
ASRT vs INCR Comparison
Compare ASRT & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRT
- INCR
- Stock Information
- Founded
- ASRT 1995
- INCR 1994
- Country
- ASRT United States
- INCR Israel
- Employees
- ASRT N/A
- INCR N/A
- Industry
- ASRT Biotechnology: Pharmaceutical Preparations
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- ASRT Health Care
- INCR Health Care
- Exchange
- ASRT Nasdaq
- INCR Nasdaq
- Market Cap
- ASRT 83.2M
- INCR 78.0M
- IPO Year
- ASRT 1997
- INCR N/A
- Fundamental
- Price
- ASRT $0.80
- INCR $1.38
- Analyst Decision
- ASRT Strong Buy
- INCR
- Analyst Count
- ASRT 1
- INCR 0
- Target Price
- ASRT $3.00
- INCR N/A
- AVG Volume (30 Days)
- ASRT 594.7K
- INCR 26.0K
- Earning Date
- ASRT 11-10-2025
- INCR 10-08-2025
- Dividend Yield
- ASRT N/A
- INCR N/A
- EPS Growth
- ASRT N/A
- INCR N/A
- EPS
- ASRT N/A
- INCR N/A
- Revenue
- ASRT $117,099,000.00
- INCR $72,158,312.00
- Revenue This Year
- ASRT N/A
- INCR $69.54
- Revenue Next Year
- ASRT $4.10
- INCR $41.75
- P/E Ratio
- ASRT N/A
- INCR N/A
- Revenue Growth
- ASRT N/A
- INCR N/A
- 52 Week Low
- ASRT $0.51
- INCR $1.17
- 52 Week High
- ASRT $1.08
- INCR $1.79
- Technical
- Relative Strength Index (RSI)
- ASRT 47.44
- INCR 40.61
- Support Level
- ASRT $0.71
- INCR $1.31
- Resistance Level
- ASRT $0.95
- INCR $1.43
- Average True Range (ATR)
- ASRT 0.05
- INCR 0.06
- MACD
- ASRT 0.01
- INCR -0.00
- Stochastic Oscillator
- ASRT 35.83
- INCR 37.50
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.